Clinuvel Pharmaceuticals Limited
CLVLY · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $517,382 | $734,623 | $888,318 | $734,982 |
| - Cash | $224,106 | $183,868 | $23,867 | $27,409 |
| + Debt | $529 | $880 | $1,000 | $1,257 |
| Enterprise Value | $293,804 | $551,634 | $865,451 | $708,829 |
| Revenue | $95,018 | $88,178 | $78,321 | $65,722 |
| % Growth | 7.8% | 12.6% | 19.2% | – |
| Gross Profit | $79,137 | $80,445 | $50,589 | $46,617 |
| % Margin | 83.3% | 91.2% | 64.6% | 70.9% |
| EBITDA | $57,197 | $56,276 | $41,699 | $33,841 |
| % Margin | 60.2% | 63.8% | 53.2% | 51.5% |
| Net Income | $36,173 | $35,636 | $30,605 | $20,878 |
| % Margin | 38.1% | 40.4% | 39.1% | 31.8% |
| EPS Diluted | 0.72 | 0.7 | 0.59 | 0.4 |
| % Growth | 2.9% | 18.6% | 47.5% | – |
| Operating Cash Flow | $41,095 | $37,054 | $36,912 | $39,872 |
| Capital Expenditures | -$299 | -$5,576 | -$1,028 | -$434 |
| Free Cash Flow | $40,797 | $31,478 | $35,885 | $39,438 |